Loading
Latest filing published 17 Mar 2023 for Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)).
No signal scores available.
All filings by Mary-Jane Eleanor Burkett on record concern Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)). In total, 2 filings cover trades dated 14 March 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 17 March 2023 came the latest disclosure, a transaction in Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)). Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations